TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,308,569 | – | 1,142,857 | – | 2.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,001,585 | $29,343,236 | 4.26% |
| Vivo Capital, LLC | 2,262,200 | $33,164 | 3.82% |
| Cormorant Asset Management, LP | 1,736,422 | $25,456 | 1.70% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,205,146 | 1.63% |
| Sands Capital Ventures, LLC | 260,000 | $3,812 | 1.04% |
| RTW INVESTMENTS, LP | 2,548,125 | $37,355,513 | 0.76% |
| Perceptive Advisors | 1,296,416 | $19,005,459 | 0.53% |
| Ghost Tree Capital, LLC | 80,000 | $1,173,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,412,977 | 0.40% |
| TimesSquare Capital Management, LLC | 1,429,310 | $20,954 | 0.30% |